General Information of DTP (ID: DT3BA8L)

DTP Name Sodium-dependent dopamine transporter (SLC6A3) DTP Info
UniProt ID
SC6A3_HUMAN
Gene Name DAT1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
5 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amphetamine DMSZQAK Attention deficit hyperactivity disorder 6A05.Z Approved [1]
Benztropine DMGZOVN Parkinson disease 8A00.0 Approved [2]
Bretylium DM1FX74 Ventricular fibrillation BC71.1 Approved [3]
Dopamine DMPGUCF Parkinson disease 8A00.0 Approved [4]
OPC-34712 DMHG57U Major depressive disorder 6A70.3 Approved [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci. 2015 Jan;36(1):41-50.
2 Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist. J Pharmacol Exp Ther. 2014 Jan;348(1):106-15.
3 Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species? J Biol Chem. 1999 Feb 19;274(8):4876-82.
4 Characterization of VNTRs Within the Entire Region of SLC6A3 and Its Association with Hypertension. DNA Cell Biol. 2017 Mar;36(3):227-236.
5 Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Psychopharmacology (Berl). 2017 Mar;234(6):1017-1028.